3White HD, French JK. Use of brain natriuretie peptide levels for risk assessment in non-ST-elevation acute coronary syndrome[J].J Am Coll Cardiol,2003,42(11) :1917-1920.
4Eggers KM, Lagerqvist B, Venge P. Prognostic value of biomarkers during and after non ST - segment elevation acute coronary syndrome[J]. J Am Coll Cardiol, 2009, 54 (4) : 357- 364.
5Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure[J]. Candiol Clin, 2001, 19(4) :557-571.
6Richards AM, Nicholls MG, Espiner EA, et al. B type natriuretic peptides and ejection fraction for prognosis after acute myocardial infarction [J]. Circulation, 2003, 107 ( 22 ): 2786 2792.
7Morrow DA,de Lemos JA,Sabatine MS,et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat- to - Zoeor Trial [J]. Circulation, 2006,114 (4) : 281-288.
8Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol , 2000,36:959.
9Feruson JL, Beckett GJ, Stoddart M, et al. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troportia, increases the apparent incidence of infarction. Heart,2002,88(4) :343.
10Meier MA, Albar WH, Cooper JV, et al. The new definition of myocardial infarction : diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med, 2002,162(14): 1585.
1Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intra- venous thrombolytic therapy for acute myocardial infarction: a quan-titative review of 23 randomised trials. Lancet, 2003, 361 (9351) : 13 -20.
2Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality predic- tion model[ J ]. Am J Cardiol ,2005,96 ( 1 ) : 35 - 41.
3Zimmermann S, Ruthrof S, Nowak K, etal. Outcomes of contemporary interventional therapy of ST elevation infarction in patients older than 75 years. Clinical Cardiology,2009,32(2) :87 -93.
4Greenberg G, Assali A, Assa - Vaknin H, etal. Outcome of patients presenting with ST elevation myocardial infarct and cardiogenic shock: a contemporary single center' s experience. Cardiology , 2012.122 (2) : 83 - 88.
5Carracitol E A, Davis K B, Sopko G, et al. Comparison of surgicall and medical group survival in patients with left main coronaryartery disease. Long - term CASS experience. Circulation, 1995, 91 : 2325 - 2334.
6Cheng JM,Valk SD,den Uil CA,etal. Usefulness of intra - aortic balloon pump eounterpulsation in patients with eardiogenie shock from acute myocardial infarction. Am J Cardiol,2009, 104:327 - 332.
7Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coro- nary intervention versus coronary - artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961 -72.
9AlJsJr S,Turkmen K,AIp&y N,et &l.lmprovernent of coron&ry flow velocity reserve with telmis&rtan in p&tients with &utosom&l-domin&nt polycystic kidney disease[J].South Med J,2010,105(6):409-413.
10Rogers PA,D&ys J,Huxng H,et &l.Ecvxsculxrizxtion improve mort&l ity in elderly p&tients with &cute myoc&rdi&i inf&rction complic&ted by c&rdiot~cnic shock[J].Znt J C&rdi&l,2014,172(1):239-241
;.
